Search results
Results from the WOW.Com Content Network
In 1996, Quintiles buys Innovex Ltd. and BRI International Inc., becoming the world's largest CRO. In 1997, Quintiles goes public, completing a successful secondary stock offering. In 1998, Quintiles becomes the first company in the industry to break the $1 billion mark, when it reports net revenues of $1.19 billion.
In May 2016, the company announced it would merge with Quintiles [21] [22] IMS Health shareholders received 0.384 shares of Quintiles common stock for each share of IMS Health common stock they held, leaving the split of ownership at 51.4% IMS and 48.6% Quintiles.
Quintiles Celebrates IPO on the New York Stock Exchange NEW YORK--(BUSINESS WIRE)-- Research Triangle Park, N.C.-based Quintiles, a leading global provider of biopharmaceutical development and ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Quintiles Announces Pricing of Initial Public Offering Stock Expected to Begin Trading on NYSE May 9th RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Quintiles today announced the pricing of its ...
For premium support please call: 800-290-4726 more ways to reach us
The top 5 best selling pharmaceuticals 2015–2019. Sales in billion USD. [1] Rank ... Eli Lilly and Company, Chugai Pharmaceutical: Osteoporosis: Dec-1997: Jan-2013 ...
For premium support please call: 800-290-4726 more ways to reach us